Postischemic functional recovery and BMIPP uptake after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction

American Journal of Cardiology

Volumn 77, Issue 1, 1996, Pages 25-30

  Hashimoto, Akiyoshi ^a   Nakata, Tomoaki ^a   Tsuchihashi, Kazufumi ^a   Tanaka, Shigemichi ^a   Fujimori, Kenji ^a   Iimura, Osamu ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

15 (4 IODOPHENYL)PENTADECANOIC ACID I 123; THALLIUM;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; FEMALE; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART VENTRICLE WALL MOTION; HEART VENTRICULOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0030069681     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)89129-1     Document Type: Article

References (29)

1. 11C-palmitate. Circulation 1981;64:689-699.
2. Schon HR, Schelbert HR, Najafi A, Hansen H, Huang H, Barrio J, Phelps ME. C-11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography: I. Kinetics of C-11 palmitic acid in normal myocardium. Am Heart J 1982;103:548-561.
3. Ter-Pogossian MM, Klein MS, Markham J, Roberts R, Sobel BE. Regional assessment of myocardial metabolic integrity in vivo by positron-emission tomography with 11C-labeled palmitate. Circulation 1980;61:242-255.
4. Marshall RC, Tillisch JH, Phelps ME, Huang SC, Carson R, Henze E, Schelbert HR. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, F-18 labeled fluorodeoxyglucose and N-13 ammonia. Circulation 1983;67:766-778.
5. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-888.
6. Tamaki N, Yonekura Y, Tamashita K, Saji H, Magata Y, Senda M, Konishi Y, Hirata K, Ban T, Konishi J. PET using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989;64:860-865.
7. Patel B, Kloner RA, Przyklenk K, Braunwald E. Postischemic myocardial "stunning": a clinically relevant phenomenon. Ann Intern Med 1988;108:626-628.
8. Bolli R. Mechanism of myocardial "stunning." Circulation 1990;82:723-734.
9. Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J, Nohara R, Kambara H, Kawai C, Ikekubo K, Kato H. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992;33:659-667.
10. Hase M, Nakata T, Yonekura S, Tsuchihashi K, Kobayashi H, Nagao K, Tanaka S, Kubota M, Tsuda T, Iimura O. Correlation of regional wall motion and fatty acid metabolism in coronary artery disease, hypertension, and hypertrophic cardiomyopathy: assessment by dual-isotope SPECT with thallium-201 and iodine-123 β-methyl fatty acid analogue. Kaku Igaku (Jpn J Nucl Med) 1993;30:529-539.
11. Nishimura T, Uehara T, Strauss HW. Radionuclide assessment of stunned myocardium by alternations in perfusion, metabolic and function. Jpn Circ J 1991; 55:913-918.
12. Kawamoto M, Tamaki N, Yonekura Y, Tadamura E, Fujibayashi Y, Magata Y, Nohara R, Sasayama S, Ikekubo K, Kato H, Konishi J. Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism. Ann Nucl Med 1994;8:47-54.
13. Tawarahara K, Kurata C, Taguchi T, Aoshima S, Okayama K, Kobayashi A, Yamazaki N, Kaneko M. Simultaneous dual myocardial imaging with iodine-123-methyl iodophenyl-pentadecanoic acid (BMIPP) and thallium-201 in patients with coronary heart disease. Jpn Circ J 1994;58:107-115.
14. Uehara T, Nishimura T, Kumita S, Shimonagata T, Hayashida K, Oka H, Saito K, Nonogi H, Haze K. Diagnostic utility of myocardial imaging using 1231-labeled beta-methyl iodophenyl pentadecanoic acid in ischemic heart disease. Kaku Igaku (Jpn J Nucl Med) 1992;29:347-358.
15. Hashimoto A, Nakata T, Nagao K, Kobayashi H, Hase M, Yoshioka N, Tsuchihashi K, Yonekura S, Tanaka S, Iimura O. Prediction of left ventricular functional recovery in patients with acute myocardial infarction using SPECT with thallium and β-methyliodophenyl pentadecanoic acid. J Cardiol 1995;26:35-44.
16. 123I-β-methyl-iodophenyl pentadecanoic acid. Eur J Nucl Med 1994;21:283-291.
17. Goodmann MM, Kirsch G, Knapp FF Jr. Synthesis and evaluation of radioiodinated terminal p-iodophenyl-substituted alpha-and beta-methyl branched fatty acids. J Med Chem 1984;27:390-397.
18. Hansen CL, Corbett JR, Pippin JJ, Jansen DE, Kulkarni PV, Ugolini V, Henderson E, Akers M, Buja LM, Parkey RW, Willerson JT. Iodine 123-phenylpentadecanoic acid and single photon emission tomography in identifying left ventricular regional metabolic abnormalities in patients with coronary heart disease: comparison with thallium-201 myocardial tomography. J Am Coll Cardiol 1988; 12:78-87.
19. Knapp FF Jr, Ambrose KR, Goodmann MM. New radioiodinated methylbranched fatty acids for cardiac studies. Eur J Nucl Med 1986;12:S39-S44.
20. Kennedy PL, Corbett JR, Kulkarni PV, Wolfe CL, Janser DE, Hansen CL, Buja LM, Parkey RW, Willerson JT. Iodine 123-phenylpentadecanoic acid myocardial scintigraphy: usefulness in the identification of myocardial ischemia. Circulation 1986;74:1007-1015.
21. Nakata T, Noto T, Uno K, Wada A, Hikita N, Tanaka S, Shoji T, Kubota M, Tsuda T, Monta K, Iimura O. Quantification of area and percentage of infarcted myocardium by single photon emission computed tomography with thallium-201: a comparison with serial serum CK-MB measurements. Ann Nucl Med 1989;3:1-8.
22. Sheehan FH, Bolson EL, Dodge HT, Mathey DG, Schofer J, Woo HW. Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation 1986;74:293-305.
23. Neely JR, Rovetto MJ, Oram JF. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 1972;15:685-698.
24. Schwaiger M, Schelbert H, Ellison D, Hansen H, Yeatman L, Vinten-Johansen J, Selin C, Barrio J, Phelps ME. Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol 1985; 6:336-347.
25. Katz AM. Oxidative metabolism. In: Katz AM, ed. Physiology of the Heart. New York: Raven Press, 1992:98-128.
26. Fujibayashi Y, Yonekura Y, Takemura Y, Wada K, Matsumoto K, Tamaki N, Yamamoto K, Konishi J, Yokoyama A. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3(R,S) methyl pentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990;31:1818-1822.
27. Rothbaum DA, Linnemeier TJ, Landin RJ, Steinmetz EF, Hillis JS, Hallam CC, Noble RJ, See MR. Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience. J Am Coll Cardiol 1987;10: 264-272.
28. O'Neill W, Timmis GC, Bourdillon PD, Lai P, Ganghadarhan V, Walton Jr J, Laufer RRN, Gordon S, Schork MA, Pitt B. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. N Engl J Med 1986;71:1121-1128.
29. Stone GW, Grines CL, Browne KF, Marco J, Rothbaum D, O'Keefe J, Hartzler GO, Overlie P, Donohue B, Chelliah N, Timmis GC, Vlietstra R, Strzelecki M, Puchrowicz-Ochoki S, O'Neill WW. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. J Am Coll Cardiol 1995;25:370-377.